feed,title,long_url,short_url
Benzinga,"MedTech Giant DexCom Spotlight Is On G7 US Launch, Analyst Forecasts 22% Revenue Gain In 2024",https://benzinga.com/analyst-ratings/analyst-color/23/10/35468867/medtech-giant-dexcom-spotlight-is-on-g7-us-launch-analyst-forecasts-22-revenue-gain,https://da.gd/byRmi
Benzinga,Pharma Giant Bristol-Myers Stock At 52-Week Low: Analyst Sees Uncertainty In Near-Term Outlook,https://benzinga.com/general/biotech/23/10/35469919/pharma-giant-bristol-myers-stock-at-52-week-low-analyst-sees-uncertainty-in-near-term-outlook,https://da.gd/P0xJF
